BlackRock, Inc. 13D and 13G filings for Catalyst Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
BLACKROCK INC BLK |
19,016,873 16.000% |
0 (Unchanged) |
Filing |
| 2024-10-18 3:31 pm Purchase |
2024-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
BLACKROCK INC BLK |
19,016,873 16.000% |
3,195,472 (+20.20%) |
Filing |
| 2024-01-22 3:52 pm Purchase |
2023-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
BLACKROCK INC BLK |
15,821,401 14.800% |
131,075 (+0.84%) |
Filing |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
BLACKROCK INC BLK |
15,690,326 15.100% |
0 (Unchanged) |
Filing |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
BLACKROCK INC BLK |
15,690,326 15.100% |
421,395 (+2.76%) |
Filing |
| 2022-10-07 2:58 pm Purchase |
2022-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
BLACKROCK INC BLK |
15,268,931 14.900% |
7,584,233 (+98.69%) |
Filing |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
BLACKROCK INC BLK |
7,684,698 7.500% |
-59,499 (-0.77%) |
Filing |
| 2021-01-28 5:55 pm Sale |
2020-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
BLACKROCK INC BLK |
7,744,197 7.500% |
-700,768 (-8.30%) |
Filing |